BIOSTAR PHARM-B(02563): Ran Dong resigns as Independent Non-Executive Director.

BIOSTAR PHARM-B (02563) announces that on April 10, 2025, Mr. Ran Dong resigned from his positions as an independent non-executive director, chairman of the audit committee, and member of the nomination committee in order to focus on handling other personal matters. In order to fill the vacancies in the roles of independent non-executive director, audit committee, and remuneration committee, and to expedite the company's compliance with Listing Rules 3.10 (1), 3.21, and 3.25 as soon as possible, the company's nomination committee, after considering individual qualifications, work experience, and expected time and effort to be devoted to the company, recommends to the Board the appointment of (i) Mr. Xiao Shuming as an independent non-executive director and member of the audit committee; and (ii) Mr. Ye Chengang as an independent non-executive director and chairman of the remuneration and assessment committee.